Navigation Links
Takeda to Acquire Nycomed
Date:5/18/2011

h: +81 3 3278 2037

For U.S. Media Inquiries:
Elissa Johnsen
E-mail: ejohnsen@tpna.com
Ph: +1 224 554 3185

For European Media Inquiries:
Rebekah Childers
E-mail: R.Childers@tgrd.com
Ph: +44 20 3116 8037

Nycomed Media and Investor Contacts:For media inquiries:
General phone:
+41 44 555 15 10Tobias Cottmann
E-mail: tobias.cottmann@nycomed.com
Ph: +41 44 555 15 01

Investors:
Christian Seidelin
christian.seidelin@nycomed.com
Ph: +41 44 555 11 04,

Seller consortium Media and Investor Contacts:Nordic Capital Fund V, Nordic Capital Fund VI
Mikael Widell
E-mail: mikael.widell@nordiccapital.com
Ph: +46 703 11 99 60

DLJ Merchant Banking Partners
Suzanne Fleming
E-Mail: suzanne.fleming@credit-suisse.com
Ph: +1 212 325 7396

Coller International Partners Capital
Axel Hansing
Axel.hansing@collercapital.com
Tel: 44 7971 224 706

Avista Capital Partners
Melissa Sheer
Jeff Taufield
+1 212 521 4800

Conference Call and Webcast InformationTakeda will host an investors conference call in English at 10:00 p.m. JST (9:00 a.m. EDT) to discuss the transaction.

[Start Time / Dial-in / Pass code]
To avoid heavy traffic on telephone lines, please dial in before 10:00 p.m.
After the presentation, you can take part in the Q&A session, please agree that this presentation and Q&A session will be broadcasted on the internet. Date

Thursday May 19, 2011 (JST) at 10:00 p.m.Start Time

New York (EST)

London (GMT)

Hong Kong (HKT)

Singapore (SST)

<
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S.
2. Takeda Doses First Patient in a U.S. Phase 1 Study of Hematide(TM) to Treat Chemotherapy Induced Anemia
3. Takeda Submits a New Drug Application in the U.S. for Alogliptin (SYR-322) / ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes
4. Takedas Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis Showed
5. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
6. Takeda Initiates Two Phase III Studies with Vedolizumab (MLN0002) in Patients with Inflammatory Bowel Disease
7. Takeda to Revise Timing of Alogliptin and Alogliptin/ACTOS MAA Filings in Europe
8. Takeda Receives FDA Complete Response Letter for Alogliptin, an Investigational Treatment for Type 2 Diabetes
9. Takeda Provides Update on the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl)
10. Takeda Initiates Cardiovascular Outcomes Trial for Alogliptin, An Investigational Treatment for Type 2 Diabetes
11. Takeda Receives FDA Complete Response Letter for the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  Mallinckrodt plc (NYSE: ... has approved a share repurchase program. The open-ended authorization ... of Mallinckrodt plc ordinary shares. "Funding ... top priorities as we continue to pursue a range ...
(Date:1/22/2015)... , Jan. 22, 2015  BiOptix is pleased to ... as Vice President of Chemistry and Biochemistry. Scott joins the ... AstraZeneca Pharmaceuticals, and Amgen throughout the course of his ... "Scott is a nationally recognized thought leader ...
(Date:1/22/2015)... Corporation (NASDAQ: TECH ) announced today that ... new Simple Plex platform through its Proteins Platform division ... of the previously acquired CyPlex instrument platform from CyVek. ... immunoassay technology which integrates an innovatively designed microfluidic cartridge ...
Breaking Medicine Technology:Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2Bio-Techne Launches Simple Plex Platform 2Bio-Techne Launches Simple Plex Platform 3
(Date:1/22/2015)... 2015 Blue Cross and Blue Shield of ... what it means to “Live Fearless.” , The ... share their stories about how they or someone they know ... by living in the moment. By telling these types of ...
(Date:1/22/2015)... January 22, 2015 The federal court overseeing ... U.S. District Court, Southern District of West Virginia has upheld ... that proceeding’s first bellwether trial. In an Order dated January ... trial after finding that C.R. Bard had not proven a ...
(Date:1/22/2015)... TX (PRWEB) January 22, 2015 A ... issue of experience and person-centeredness in the long-term care ... towards action across the continuum. The paper, “The Power ... Continuum,” engages perspectives and practices of the patient, resident ...
(Date:1/22/2015)... January 22, 2015 Autocarinsurancebest.com has released a ... a commercial auto insurance policy . , Auto insurance ... vehicles. It is no longer necessary to call an agent ... now available online on a single website: http://autocarinsurancebest.com/ . ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post presenting the ... , Purchasing an accidental death and dismemberment rider for ... of rider provides benefits if the insured dies in an ... form of life insurance. , AD&D is not expensive ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2
... , FRIDAY, Sept. 9 (HealthDay News) -- Good hygiene ... bacterial and viral infections, according to the U.S. Centers ... growing concern that strict adherence to good hygiene, though ... open to other forms of illness. Proponents of ...
... -- More than one-half of all adverse drug reactions ... to a new study. In addition, prior research ... include drug overdoses and internal bleeding associated with the ... life-threatening, said the Swedish researchers. This widespread problem, which ...
... News) -- Having control over how to communicate with ... patients cope with their situation, according to a new ... Austin interviewed cancer survivors about strategies they used in ... about their condition, challenges they faced, advice they received, ...
... finds that lung cancer patients treated in hospitals ... and Medicaid-insured patients, so-called "high safety-net burden facilities," ... was intended to cure the cancer compared to ... difference persisted even after controlling for other factors ...
... Reinberg HealthDay Reporter , FRIDAY, Sept. 9 ... and Drug Administration were to meet Friday to discuss ... as Fosamax, Actonel, Boniva and Reclast. These ... related to postmenopausal osteoporosis. But researchers have linked long-term ...
... vaccine Cervarix may be just as effective as the standard ... cancer, according to a new study published September 9 in ... Across the globe, cervical cancer is the third most ... are a large contributor to the development of the disease. ...
Cached Medicine News:Health News:A Little Dirt May Be a Good Thing 2Health News:A Little Dirt May Be a Good Thing 3Health News:Over Half of Adverse Drug Reactions in Hospitals Are Preventable: Study 2Health News:Talking -- or Not Talking -- Can Give Cancer Patients a Sense of Control 2Health News:Study finds hospitals of last resort deliver lower quality of lung cancer care 2Health News:Osteoporosis Drugs' Safety Subject of FDA Panel 2Health News:Osteoporosis Drugs' Safety Subject of FDA Panel 3Health News:Fewer than 3 doses of cervical cancer vaccine effective 2
... chairs with concave seats and standard-sized ... options like seats, backrests, armrests, and ... are recommended for the following environments: ... control, health care and office. • ...
... Basic ergonomic chairs with ... with lumbar support • Select ... and casters and glides. • ... the following environments: industry, education, ...
... Basic ergonomic chairs with concave seats ... • Select options like seats, backrests, ... BTT/1P chairs are recommended for the ... room, static control, health care and ...
... with concave seats and large backrests ... like seats, backrests, armrests, and casters ... Series for top performance in a ... laboratory, clean room, static control, health ...
Medicine Products: